Olympus Stem Cells Pty Ltd Australia Demonstrating Superior Stem Cell Numbers and Viability in Treatment for Neuropathy

April 12, 2018
Download as PDF Single Release RSS Feed
Facebook Twitter Google Digg Reddit LinkedIn Email

Olympus Stem Cells in Australia are achieving stem cell numbers approximating 6 million stem cells per gram of tissue and excellent cell viability of up to 100% confirmed with Muse Analyzer testing.

Medical clinic and research facility Olympus Stem Cells Pty Ltd, based in Sydney Olympic Park, NSW, Australia, are pleased to announce the results of achieving 6 million stem cells per gram of tissue in recent clinical studies and treatment.

Olympus Stem Cells treat:

-Neuropathic Pain of the Head and Neck

-Dry Eyes from Sjogrens and aging conditions

-Painful eyes from post LASIK neuropathy

-Dry mouth from Sjogrens and radiation xerostomia

-Alopecia Andogenetica

-Bells Palsy

-Facial Pain from symptoms associated with Multiple Sclerosis

-Facial aging and wrinkles

-Empty Nose Syndrome

Stem Cell numbers and validation of stem cell viability are confirmed with Muse cell analyzer technology as described by Millipore Merck. More details can be obtained from http://www.olympusstemcells.com.au or http://www.merckmillipore.com

The Director of Olympus Stem Cells, Associate Professor Russell Vickers, is an acknowledged world authority in the use of stem cells to treat neuropathic pain, dry eyes (keratoconjunctivitis sicca), dry mouth (xerostomia), symptoms of MS related to facial pain, osteoarthritis of the Temporomandibular joint and hair regeneration.

He is pleased to offer stem cell services including consultations and treatment amongst the 5 medical centres in Sydney Australia. Associate Professor Russell Vickers, has published extensively on the use of stem cells in neuropathic facial pain, stem cell protocols and is a leader in his field. He is conducting clinical treatment of MS patients with the clinical symptoms of facial pain and has expanded this to patients with Empty Nose Syndrome, a complex painful disorder that is especially distressing to patients. Empty Nose Syndrome may follow sinus surgery, septoplasty or other ENT procedures involving the nasal complex.

Associate Professor Vickers sources the abdominal fat for adipose derived stem cells. He processes the fat and obtains stem cell concentrations that are extremely generous in numbers and quality. As a consultant surgeon he then delivers the stem cells to the anatomical area requiring the specific treatment.

Associate Professor Vickers utilises a vast array of medical scientific equipment in his quest to offer the very best of stem cell treatment. For validation he uses the Muse Cell Analyser and has been achieving up to 100% of stem cell viability. Additionally Olympus Stem Cells Pty Ltd has the availability of its own Mass Spectrometer and cell counting technology. In many conditions Stem Cell Therapy is a highly effective means of alleviating pain and discomfort for people suffering a variety of conditions ranging from MS to neuropathic facial pain.

The numbers of Stem Cells are important as they differentiate to the cell required for regeneration and restoration of structure and function.

Associate Professor Vickers has published in peer reviewed journals the efficacy of his treatment. They are proud to be one of Sydney's best Stem Cell Therapy providers, with a proven track record of providing safe, effective treatment and expert care for their patients. Olympus has a strong focus on research and development and is working hard to constantly further the advancement of stem cell techniques around the world. Their research has been published internationally in peer-reviewed medical and science journals, plus theirlaboratory boasts some of the best state-of-the-art biotechnology equipment in Australia.

Olympus Stem Cells Pty Ltd is one of the few companies undertaking ground breaking stem cell treatment in Australia and the Asia-Pacific region.

More information on the Olympus clinics and the work that they do can be obtained at http://www.olympushealthgroup.com.au.

Associate Professor Vickers' recent research publications pertaining to genetics, stem cells and facial pain are extensive. These publications include Human Brain Mapping, the Australian Endodontic Journal, Hair Therapy and Transplantation, The Journal of Neuroscience, Diagnosing Dental and Orofacial Pain, the Journal of the Australian Society of Cosmetic Chemists, Medicine Today (The Journal of the Royal Australian College of General Practitioners), the Open Journal of Dentistry and Oral Medicine, and the Journal of Pain Research. More information on Associate Professor Vickers' work can be obtained at http://www.clinicalstemcells.com.

Contact Olympus Stem Cells Pty Ltd:

Professor Russell Vickers
+61 4277 11 888
[email protected]
Olympus Stem Cell Centre, Sydney Olympic Park, 5 Australia Avenue, Sydney Olympic Park, NSW, Australia



SOURCE: Press Advantage [Link]

Download as PDF Single Release RSS Feed
Facebook Twitter Google Digg Reddit LinkedIn Email

About Olympus Stem Cells Pty Ltd:

Olympus Stem Cells Pty Ltd are a clinical research and development biotech company engaged in stem cell therapy in Sydney, Australia.

Contact Olympus Stem Cells Pty Ltd:

Professor Russell Vickers
Olympus Stem Cell Centre,
Sydney Olympic Park,
5 Australia Avenue,
Sydney Olympic Park,
NSW, Australia.
+61 4277 11 888
http://www.olympusstemcells.com.au

This News Release Was Picked Up By These Local News Sites:

Yahoo! Finance
Digital Journal
FinancialContent
FinancialContent

Additional News Releases From Olympus Stem Cells Pty Ltd:

April 12, 2018Stem Cells For Hair Regeneration

April 04, 2018Dry Mouth from Sjogren’s Syndrome or Head and Neck Radiation: Olympus Stem Cells Advise Technical Considerations in Surgery

April 03, 2018Dry Eyes and Stem Cells: Olympus Stem Cells Advise Technical Considerations in Surgery

April 02, 2018Olympus Stem Cells Using Zinc Thymulin, Micro-Fat Grafting and Stem Cells for Baldness

April 02, 2018Olympus Stem Cells Using Palmitoylethanolamide (PEA) and Stem Cells for Control of Disabling Facial Neuropathic Pain

March 26, 2018Olympus Stem Cells Pty Ltd Highlight Relationship Between Goblet Cells, Neuropathic Pain and Post LASIK Dry Eye Syndrome

March 26, 2018Olympus Stem Cells Pty Ltd Highlight Relationship Between Neural Crest Cells and Neuropathic Pain in Empty Nose Syndrome

March 19, 2018Olympus Genetics Pty Ltd Presents The Invitae Proactive Genetic Testing Panel to Mackay Oral and MaxilloFacial Surgery Under Leadership of Dr Anthony Oliver at Mackay, Queensland, Australia

March 19, 2018Clinical Stem Cells Pty Ltd Awarded USA and Worldwide Patent for Hair Regeneration